EDIT Competitors & Alternatives
Compare Editas Medicine Inc with similar stocks in the same industry
Biotechnology
EDIT
Main Stock$2.52
Tradestie Score
65
Market Cap
$319.22M
Revenue Growth
2.3%
Analyst Upside
+134.1%
Top Competitors
230 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
ATXS
Astria Therapeutics, Inc. Common Stock
|
$12.58
|
$425.52M | - | 54 | Compare |
|
ALMS
Alumis Inc. Common Stock
|
$7.21
|
$422.50M | - | 55 | Compare |
|
PACB
Pacific Biosciences of California, Inc.
|
$2.51
|
$414.51M | - | 42 | Compare |
|
FDMT
4D Molecular Therapeutics, Inc. Common Stock
|
$13.84
|
$407.71M | - | 56 | Compare |
|
DSGN
Design Therapeutics, Inc. Common Stock
|
$12.24
|
$386.68M | - | 69 | Compare |
|
AURA
Aura Biosciences, Inc. Common Stock
|
$6.04
|
$382.04M | - | 58 | Compare |
|
DRTS
Alpha Tau Medical Ltd. Ordinary Shares
|
$14.51
|
$371.64M | - | 47 | Compare |
|
CAPR
Capricor Therapeutics Inc
|
$8.94
|
$357.51M | - | 40 | Compare |
|
CGEM
Cullinan Therapeutics, Inc. Common Stock
|
$14.53
|
$354.45M | - | 61 | Compare |
|
LBRX
LB Pharmaceuticals Inc Common Stock
|
$37.28
|
$353.70M | - | 63 | Compare |
More EDIT Analysis
Data updated: Oct 02, 2026 | Industry: Biotechnology (SIC 2836)
230 stocks in this industry